36. Bessey PQ, Watters JM, Aoki TT, et al. Combined hormonal infusion simulates the metabolic

response to injury. Ann Surg 1984;200:264–281.

37. Anker SD, Coats AJ. Cardiac cachexia: a syndrome with impaired survival and immune and

neuroendocrine activation. Chest 1999;115:836–847.

38. Gentile LF, Cuenca AG, Efron PA, et al. Persistent inflammation and immunosuppression: a

common syndrome and new horizon for surgical intensive care. J Trauma Acute Care Surg

2012;72:1491–1501.

39. Vanzant EL, Lopez CM, Ozrazgat-Baslanti T, et al. Persistent inflammation, immunosuppression,

and catabolism syndrome after severe blunt trauma. J Trauma Acute Care Surg 2014;76:21–29;

discussion 9–30.

40. Ruiz Garcia V, López-Briz E, Carbonell Sanchis R, et al. Megestrol acetate for treatment of anorexiacachexia syndrome. Cochrane Database Syst Rev 2013;3:CD004310.

41. Barber MD, Ross JA, Voss AC, et al. The effect of an oral nutritional supplement enriched with fish

oil on weight-loss in patients with pancreatic cancer. Br J Cancer 1999;81:80–86.

42. Gogos CA, Ginopoulos P, Salsa B, et al. Dietary omega-3 polyunsaturated fatty acids plus vitamin E

restore immunodeficiency and prolong survival for severely ill patients with generalized

malignancy: a randomized control trial. Cancer 1998;82:395–402.

43. Neville AL, Brown CV, Weng J, et al. Obesity is an independent risk factor of mortality in severely

injured blunt trauma patients. Arch Surg 2004;139:983–987.

44. Enomoto TM, Larson D, Martindale RG. Patients requiring perioperative nutritional support. Med

Clin North Am 2013;97:1181–1200.

45. Smedley F, Bowling T, James M, et al. Randomized clinical trial of the effects of preoperative and

postoperative oral nutritional supplements on clinical course and cost of care. Br J Surg

2004;91:983–990.

46. Wolfe RR. Perspective: optimal protein intake in the elderly. J Am Med Dir Assoc 2013;14:65–66.

47. Alberda C, Gramlich L, Jones N, et al. The relationship between nutritional intake and clinical

outcomes in critically ill patients: results of an international multicenter observational study.

Intensive Care Med 2009;35:1728–1737.

48. Martindale RG, McClave SA, Vanek VW, et al. Guidelines for the provision and assessment of

nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine and

American Society for Parenteral and Enteral Nutrition: Executive Summary. Crit Care Med

2009;37:1757–1761.

49. Singer P, Berger MM, Van den Berghe G, et al. ESPEN guidelines on parenteral nutrition: intensive

care. Clin Nutr 2009;28:387–400.

50. Casaer MP, Van den Berghe G. Nutrition in the acute phase of critical illness. N Eng J Med

2014;370:1227–1236.

51. Artinian V, Krayem H, DiGiovine B. Effects of early enteral feeding on the outcome of critically ill

mechanically ventilated medical patients. Chest 2006;129:960–967.

52. Meyfroidt G, Ingels C, Van den Berghe G. Glycemic control in the ICU. N Eng J Med 2011;364:1280;

author reply 1281.

53. Singer P, Anbar R, Cohen J, et al. The tight calorie control study (TICACOS): a prospective,

randomized, controlled pilot study of nutritional support in critically ill patients. Intensive Care Med

2011;37:601–609.

54. Frankenfield DC, Ashcraft CM. Estimating energy needs in nutrition support patients. JPEN J

Parenter Enteral Nutr 2011;35:563–570.

55. Martin CM, Doig GS, Heyland DK, et al.; Southwestern Ontario Critical Care Research Network.

Multicentre, cluster-randomized clinical trial of algorithms for critical-care enteral and parenteral

therapy (ACCEPT). CMAJ 2004;170:197–204.

56. Doig GS, Simpson F, Finfer S, et al. Effect of evidence-based feeding guidelines on mortality of

critically ill adults: a cluster randomized controlled trial. JAMA 2008;300:2731–2741.

57. Rice TW, Wheeler AP, Thompson BT, et al.; National Heart Lung and Blood Institute Acute

Respiratory Distress Syndrome Clinical Trials Network. Initial trophic vs full enteral feeding in

patients with acute lung injury: the EDEN randomized trial. JAMA 2012;307:795–803.

58. Montejo JC, Minambres E, Bordeje L, et al. Gastric residual volume during enteral nutrition in ICU

99

patients: the REGANE study. Int Care Med 2010;36:1386–1393.

59. Davies AR, Morrison SS, Bailey MJ, et al. A multicenter, randomized controlled trial comparing

early nasojejunal with nasogastric nutrition in critical illness. Crit Care Med 2012;40:2342–2348.

60. Acosta-Escribano J, Fernandez-Vivas M, Grau Carmona T, et al. Gastric versus transpyloric feeding

in severe traumatic brain injury: a prospective, randomized trial. Intensive Care Med 2010;36:1532–

1539.

61. Nguyen NQ, Chapman MJ, Fraser RJ, et al. Erythromycin is more effective than metoclopramide in

the treatment of feed intolerance in critical illness. Crit Care Med 2007;35:483–489.

62. MacLaren R, Kiser TH, Fish DN, et al. Erythromycin vs metoclopramide for facilitating gastric

emptying and tolerance to intragastric nutrition in critically ill patients. JPEN J Parenter Enteral Nutr

2008;32:412–419.

63. Pontes-Arruda A, Aragao AM, Albuquerque JD. Effects of enteral feeding with eicosapentaenoic

acid, gamma-linolenic acid, and antioxidants in mechanically ventilated patients with severe sepsis

and septic shock. Crit Care Med 2006;34:2325–2333.

64. Peter JV, Moran JL, Phillips-Hughes J. A metaanalysis of treatment outcomes of early enteral

versus early parenteral nutrition in hospitalized patients. Crit Care Med 2005;33:213–220; discussion

60–61.

65. van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N

Eng J Med 2001;345:1359–1367.

66. Dissanaike S, Shelton M, Warner K, et al. The risk for bloodstream infections is associated with

increased parenteral caloric intake in patients receiving parenteral nutrition. Crit Care

2007;11:R114.

67. Grau T, Bonet A, Rubio M, et al. Liver dysfunction associated with artificial nutrition in critically ill

patients. Crit Care 2007;11:R10.

68. Casaer MP, Mesotten D, Hermans G, et al. Early versus late parenteral nutrition in critically ill

adults. N Eng J Med 2011;365:506–517.

69. Hermans G, Casaer MP, Clerckx B, et al. Effect of tolerating macronutrient deficit on the

development of intensive-care unit acquired weakness: a subanalysis of the EPaNIC trial. Lancet

Respir Med 2013;1:621–629.

70. Vanderheyden S, Casaer MP, Kesteloot K, et al. Early versus late parenteral nutrition in ICU

patients: cost analysis of the EPaNIC trial. Crit Care 2012;16:R96.

71. Casaer MP, Wilmer A, Hermans G, et al. Role of disease and macronutrient dose in the randomized

controlled EPaNIC trial: a post hoc analysis. Am J Respir Crit Care Med 2013;187:247–255.

72. Heidegger CP, Berger MM, Graf S, et al. Optimisation of energy provision with supplemental

parenteral nutrition in critically ill patients: a randomised controlled clinical trial. Lancet

2013;381:385–393.

73. Doig GS, Simpson F, Sweetman EA, et al. Early parenteral nutrition in critically ill patients with

short-term relative contraindications to early enteral nutrition: a randomized controlled trial. JAMA

2013;309:2130–2138.

74. Braunschweig CL, Levy P, Sheean PM, et al. Enteral compared with parenteral nutrition: a metaanalysis. Am J Clin Nutr 2001;74:534–542.

75. Battistella FD, Widergren JT, Anderson JT, et al. A prospective, randomized trial of intravenous fat

emulsion administration in trauma victims requiring total parenteral nutrition. J Trauma

1997;43:52–58; discussion 58–60.

76. Stapleton RD, Martin JM, Mayer K. Fish oil in critical illness: mechanisms and clinical applications.

Crit Care Clin 2010;26:501–514, ix.

77. Mehanna HM, Moledina J, Travis J. Refeeding syndrome: what it is, and how to prevent and treat

it. BMJ 2008;336:1495–1498.

78. Bagga D, Wang L, Farias-Eisner R, et al. Differential effects of prostaglandin derived from omega-6

and omega-3 polyunsaturated fatty acids on COX-2 expression and IL-6 secretion. Proc Natl Acad Sci

U S A 2003;100:1751–1756.

79. Fong YM, Marano MA, Barber A, et al. Total parenteral nutrition and bowel rest modify the

metabolic response to endotoxin in humans. Ann Surg 1989;210:449–456; discussion 56–57.

80. Harvey SE, Parrott F, Harrison DA, et al. Trial of the route of early nutritional support in critically

100

http://surgerybook.net/

ill adults. N Eng J Med 2014;371(18):1673–1684.

81. Kiyama T, Onda M, Tokunaga A, et al. Effect of early postoperative feeding on the healing of

colonic anastomoses in the presence of intra-abdominal sepsis in rats. Dis Colon Rectum

2000;43:S54–S58.

82. Chin KF, Townsend S, Wong W, et al. A prospective cohort study of feeding needle catheter

jejunostomy in an upper gastrointestinal surgical unit. Clin Nutr 2004;23:691–696.

83. Taylor SJ, Fettes SB, Jewkes C, et al. Prospective, randomized, controlled trial to determine the

effect of early enhanced enteral nutrition on clinical outcome in mechanically ventilated patients

suffering head injury. Crit Care Med 1999;27:2525–2531.

84. Cook D, Arabi Y. The route of early nutrition in critical illness. N Eng J Med 2014;371(18):1748–

1749.

85. McClave SA, Heyland DK. The physiologic response and associated clinical benefits from provision

of early enteral nutrition. Nutr Clin Pract 2009;24:305–315.

86. Flordelis Lasierra JL, Perez-Vela JL, Montejo Gonzalez JC. Enteral nutrition in the

hemodynamically unstable critically ill patient. Med Intensiva 2014;39(1):40–48.

87. Guillaume A, Seres DS. Safety of enteral feeding in patients with open abdomen, upper

gastrointestinal bleed, and perforation peritonitis. Nutr Clin Pract 2012;27:513–520.

88. Patel JJ, Kozeniecki M, Biesboer A, et al. Early trophic enteral nutrition is associated with

improved outcomes in mechanically ventilated patients with septic shock: a retrospective review. J

Intensive Care Med 2014. (PMID 25315218).

89. Seder CW, Janczyk R. The routine bridling of nasojejunal tubes is a safe and effective method of

reducing dislodgement in the intensive care unit. Nutr Clin Pract 2008;23:651–654.

90. Scheinkestel CD, Kar L, Marshall K, et al. Prospective randomized trial to assess caloric and protein

needs of critically ill, anuric, ventilated patients requiring continuous renal replacement therapy.

Nutrition 2003;19:909–916.

91. Novak F, Heyland DK, Avenell A, et al. Glutamine supplementation in serious illness: a systematic

review of the evidence. Crit Care Med 2002;30:2022–2029.

92. Andrews PJ, Avenell A, Noble DW, et al. Randomised trial of glutamine, selenium, or both, to

supplement parenteral nutrition for critically ill patients. BMJ 2011;342:d1542.

93. Heyland D, Muscedere J, Wischmeyer PE, et al. A randomized trial of glutamine and antioxidants in

critically ill patients. N Eng J Med 2013;368:1489–1497.

94. Wernerman J, Kirketeig T, Andersson B, et al. Scandinavian glutamine trial: a pragmatic multicentre randomised clinical trial of intensive care unit patients. Acta Anaesthesiol Scand 2011;55:812–

818.

95. Bollhalder L, Pfeil AM, Tomonaga Y, et al. A systematic literature review and meta-analysis of

randomized clinical trials of parenteral glutamine supplementation. Clin Nutr 2013;32:213–223.

96. Marik PE, Zaloga GP. Immunonutrition in critically ill patients: a systematic review and analysis of

the literature. Intensive Care Med 2008;34:1980–1990.

97. Wanten GJ, Calder PC. Immune modulation by parenteral lipid emulsions. Am J Clin Nutr

2007;85:1171–1184.

98. Ferrie S. Re: The use of an inflammation-modulating diet in patients with acute lung injury or acute

respiratory distress syndrome: a meta-analysis of outcome data. JPEN J Parenter Enteral Nutr

2010;34:452; author reply 453–454.

99. Pontes-Arruda A, Martins LF, de Lima SM, et al. Enteral nutrition with eicosapentaenoic acid,

gamma-linolenic acid and antioxidants in the early treatment of sepsis: results from a multicenter,

prospective, randomized, double-blinded, controlled study: the INTERSEPT study. Crit Care

2011;15:R144.

100. Umpierrez GE, Spiegelman R, Zhao V, et al. A double-blind, randomized clinical trial comparing

soybean oil-based versus olive oil-based lipid emulsions in adult medical-surgical intensive care unit

patients requiring parenteral nutrition. Crit Care Med 2012;40:1792–1798.

101. Manzanares W, Dhaliwal R, Jurewitsch B, et al. Parenteral fish oil lipid emulsions in the critically

ill: a systematic review and meta-analysis. JPEN J Parenter Enteral Nutr 2014;38:20–28.

102. Manzanares W, Dhaliwal R, Jiang X, et al. Antioxidant micronutrients in the critically ill: a

systematic review and meta-analysis. Crit Care 2012;16:R66.

101